NEW YORK, March 08, 2024 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Life Science Virtual Investor ...

Prezent, the communications platform trusted by over 150 Life Sciences companies including 45 of the top 50 BioPharma, today ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in ...

According to research from McKinsey, nearly a quarter of life sciences organizations had already deployed GenAI at scale ...

We are thrilled that our Phase 2a study of intranasal foralumab in Multiple System Atrophy has been selected as a late-breaking poster at the 7th World Parkinson Congress,” said Ivor Elrifi, CEO of ...

Presentation to highlight WVE-007 (INHBE GalNAc-siRNA) as a potential novel and unique obesity treatment leading to healthy weight loss and supporting preclinical data demonstrating potent and durable ...

Three posters accepted at AACR 2026 highlighting SK Life Science Labs' targeted protein degradation pipeline -- Programs featured: selective p300 and PRMT5 degraders -- p300 degrader data demonstrate: ...

When I returned to Philadelphia in early 2016, after more than 20 years on the West Coast, the life sciences community here was gaining momentum. A decade later, some of that grassroots enthusiasm has ...

NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that presentations from the Life Sciences Virtual ...

To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com. About Virtual Investor Conferences® ...